News & Articles

Microsemi CRP hematology analyzers have been installed during COVID-19 ‘lockdown’ in POC locations to help reduce hospital admissions

The cPass™ – SARS-CoV-2 Surrogate Virus Neutralization Test (sVNT) Kit aims to detect the presence of neutralizing antibodies in an hour

Interim clinical study data shows ID NOW test performance of 94.7% sensitivity and 98.6% specificity

Driven by the gap in COVID-19 testing, the collaboration aims to create a fully disposable, rapid and handheld test for consumers

A qualitative test for the detection of nucleic acid from SARS-CoV-2

Study suggests that type I IFN deficiency in the blood could help define a high-risk population

The COVID-19 vaccine trial is part of a global development program that will uncover the safety and immunogenicity of four mRNA vaccine candidates.

Test deployed on Quanterix' Simoa platform promises 1,000-fold sensitivity improvement

The company says it continues to optimize its coronavirus test amid questions about its accuracy

The digital tool could help simplify the screening, diagnosis and monitoring of patients with respiratory compromise in the current COVID-19 pandemic

A portable and non-invasive, fingerprint-based method, ideal for on-site testing in care homes and the workplace

Leading HPLC analyzer manufacturer Tosoh Europe partners with EKF for Quo-Test HbA1c point-of-care analyzer

Mass production comes as part of a nationwide effort to support the NHS in the fight against COVID-19

The Alinity m molecular laboratory COVID-19 test instrument claims it can run up to 1,080 tests in 24 hours

A research team at the University of Cambridge has designed a ventilator for treating COVID-19 patients that can be quickly and cheaply manufactured

Register today to reserve a place at the Summit - it opens at 13:00 (BST) / 14:00 (CEST) / 08:00 (EDT) / 05:00 (PDT) on Monday, May 11

AMSBIO's new service utilizes their novel lentiviral system to aid the development of therapeutic drugs and vaccines

Innovosens building partnerships to accelerate development, testing and market launch

The blood-based immunoassay test enables clinicians to identify the virus linked with COVID-19

The serology test promises 100% sensitivity and can help assess patients' immune response to the virus

The company aims to provide solutions for the pandemic through close collaboration with scientists and providing cutting-edge laboratory equipment